Harbin Pharmaceutical Group Co. Ltd. A | Ownership
Companies that own Harbin Pharmaceutical Group Co. Ltd. A
China Investment Corp. (Investment Management)
48,833,200
1.96%
0
0.08%
03/31/2018
China Life Asset Management Co., Ltd.
29,629,886
1.19%
7,523,803
0.18%
03/31/2018
Huatai-PineBridge Fund Management Co., Ltd.
24,290,778
0.97%
14,611,713
0.28%
12/31/2017
Guotai Asset Management Co., Ltd.
8,120,215
0.33%
1,648,609
0.07%
12/31/2017
China Southern Asset Management Co., Ltd.
6,816,505
0.27%
-912,315
0.03%
12/31/2017
Chang Xin Asset Management Co., Ltd.
3,661,600
0.15%
2,227,700
0.08%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
3,065,200
0.12%
2,935,800
0.2%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
3,043,200
0.12%
1,501,600
0.11%
12/31/2017
China Asset Management Co., Ltd.
2,644,194
0.11%
-2,295,500
0.01%
12/31/2017
Beixin Ruifeng Fund Management Co. Ltd.
2,580,000
0.1%
0
0.04%
12/31/2017
| Address |
No. 7 Qunli Avenue
Harbin Heilongjiang 150070
China
|
|
Employees
|
- |
| Website |
http://www.hayao.com |
| Updated |
07/08/2019 |
| Harbin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, wholesale, and retail of pharmaceutical products. It pharmaceutical covers chemical raw materials, chemical agents, biological agents, Chinese medicine, and health care products. It specializes in anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs, and nutritional supplements. |
